XML 36 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Geographic and Product Data
 12 Months Ended
Jan. 01, 2016
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 16 — Geographic and Product Data
 
The Company markets and sells its products in approximately 60 countries and has manufacturing in the United States. Other than the United States, Japan, Korea, China, and Spain, the Company does not conduct business in any country in which its sales in that country exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s sales to unaffiliated customers is set forth below (in thousands):
 
Net sales to unaffiliated customers
 
2015
 
2014
 
2013
 
United States
 
$
10,904
 
$
11,117
 
$
12,851
 
Japan
 
 
16,982
 
 
19,107
 
 
17,666
 
China
 
 
12,571
 
 
9,370
 
 
8,618
 
Korea
 
 
8,061
 
 
6,563
 
 
7,743
 
Spain
 
 
5,617
 
 
5,562
 
 
4,867
 
Others*
 
 
22,988
 
 
23,268
 
 
20,470
 
Total
 
$
77,123
 
$
74,987
 
$
72,215
 
 
*No other location individually exceeds 5% of total sales.
 
100% of the Company’s sales are generated from the ophthalmic surgical product segment and, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.   The composition of the Company’s net sales by product line is as follows (in thousands):
 
Net sales by product line
 
2015
 
2014
 
2013
 
ICLs
 
$
51,543
 
$
44,047
 
$
44,128
 
IOLs
 
 
19,857
 
 
24,336
 
 
24,153
 
Other surgical products
 
 
5,723
 
 
6,604
 
 
3,934
 
Total
 
$
77,123
 
$
74,987
 
$
72,215
 
 
The composition of the Company’s long-lived assets, consisting of property and equipment, between those in the United States, Switzerland, and Japan is set forth below (in thousands):
 
Long-lived assets
 
2015
 
2014
 
U.S.
 
$
9,048
 
$
9,127
 
Switzerland
 
 
672
 
 
596
 
Japan
 
 
375
 
 
343
 
Total
 
$
10,095
 
$
10,066
 
 
The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.